Markets

Market Nav

News Details

07/05/2025 11:36

Bafna Pharmaceutical - Disclosure under SEBI Takeover Regulations

SRJR LIFESCIENCES LLP has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.